Nutra Pharma Corporation Announces Resignation of Marcum LLP as Independent Auditor, Cites Internal Control Weaknesses

Reuters
09/04
<a href="https://laohu8.com/S/NPHC">Nutra Pharma</a> Corporation Announces Resignation of Marcum LLP as Independent Auditor, Cites Internal Control Weaknesses

Nutra Pharma Corporation has announced a change in its certifying accountants. On March 27, 2024, Marcum LLP resigned as the company's independent registered public accounting firm. Marcum had only reviewed Nutra Pharma's financial reports for the quarters ending June 30, 2022, and September 30, 2022, and did not audit any periods before or after these dates. During Marcum's tenure, there were no disagreements or reportable events with the company, except for material weaknesses in internal control, including a lack of qualified accounting personnel and inadequate segregation of duties. On December 18, 2024, Nutra Pharma's Board of Directors approved the engagement of Astra Audit & Advisory as the new independent registered public accounting firm for the fiscal year ending December 31, 2022.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutra Pharma Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-026384), on September 03, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10